Bank of America
SCMP

Bank of America’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Bank of America’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-25,000
Closed -$449K – 7560
2017
Q4 		$449K Buy
+25,000
New +$308K ﹤0.01% 5013

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Bank of America's SCMP Position: Q1 2018 in Review

Bank of America sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 31,063 shares — an estimated $556K sold.

Bank of America first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $1.3M in Q3 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Bank of America reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Bank of America sold 31,063 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $556K.
  • Bank of America first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
  • Bank of America's Sucampo Pharmaceuticals, Inc. position peaked at $1.3M in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Bank of America's 13F filing for Q1 2018, filed 15 May 2018.